Fig 1: The ROC curve of ICP, caspase-3. The area under the curve (AUC) for ICP was 0.925, and caspase-3 was 0.888. The AUC for the combined marker was 0.978, which showed that the combined marker was more reliable than that separately.
Fig 2: MiR-186-3p inhibits the development of cervical cancer cells. A qRT-PCR detection of the relative expression of miR-186-3p in non-tumor tissues and tumor tissues. P < 0.001 using Student’s t test. B qRT-PCR detection of the relative expression of miR-186 in HcerEpic, HeLa, CaSKi, SiHa, and C33A cells. ** P < 0.001 compared with HcerEpic cells using ANOVA. C qRT-PCR detection of the relative expression of miR-186-3p in HeLa and SiHa cells transfected with miR-186-3p mimic and inhibitor and NC. D MTT assay detection of the viability of HeLa and SiHa cells transfected with miR-186-3p mimic and inhibitor and NC. E BrdU assay determination of the proliferation of HeLa and SiHa cells transfected with miR-186-3p mimic and inhibitor and NC. F Transwell assay measurement of the migration ability of HeLa and SiHa cells transfected with miR-186-3p mimic and inhibitor and NC. G Caspase-3 activity assay detection of cell apoptosis of HeLa and SiHa cells transfected with miR-186-3p mimic and inhibitor and NC. H Western blotting detection of the expression of cleaved caspase-3 and total caspase-3 in HeLa and SiHa cells transfected with miR-186-3p mimic and inhibitor and NC. C–H **, P < 0.001 compared with blank control (CON) group using ANOVA. Other abbreviations: NC, negative control; miR-mimic, miR-186-3p mimic; miR-inhibitor, miR-186-3p inhibitor
Fig 3: Inhibition of miR-143-3p reduces cell proliferation and promotes cell apoptosis. (A) Transfection of miR-143-3p inhibitor in MH7A cells. **P<0.01 vs. control. (B) Effect of TNF-a treatment and transfection with miR-143-3p inhibitor on cell proliferation and (C and D) apoptosis. (E and F) Effect of TNF-a treatment and miR-143-3p inhibition on the expression of Bax, Bcl-2, pro-caspase-3 and active caspase-3. Data are presented as the mean ± standard deviation from at least three independent experiments. *P<0.05 and **P<0.01 vs. control; #P<0.05 vs. inhibitor NC group. TNF, tumor necrosis factor; miR, microRNA; OD, optical density; NC, negative control.
Fig 4: Pearson correlation coefficient analysis of the relationship between the expression levels of miR-146b and miR-155, and concentrations of the parameters related with myocarditis in Treg cells. (A) The relationship between the expression levels of miR-146b and concentration of CK-MB. (B) The relationship between the expression levels of miR-146b and concentration of cTnI. (C) The relationship between the expression levels of miR-146b and concentration of GrB. (D) The relationship between the expression levels of miR-146b and concentration of sFasL. (E) The relationship between the expression levels of miR-146b and concentration of caspase-3. (F) The relationship between the expression levels of miR-155 and concentration of CK-MB. (G) The relationship between the expression levels of miR-155 and concentration of cTnI. (H) The relationship between the expression levels of miR-155 and concentration of GrB. (I) The relationship between the expression levels of miR-155 and concentration of sFasL. (J) The relationship between the expression levels of miR-155 and concentration of caspase-3. There is a strong positive relation between two variables if rho falls within from 0.5 to 1. The levels of CK-MB, cTnI, GrB, and sFasL were positively associated with the levels of miR-146b and miR-155.
Fig 5: Biological evaluation following cryopreservation of ADSC-laden gellan gum–collagen hydrogels using trehalose. (A) Cell viability of encapsulated ADSCs cryopreserved with 10% DMSO or varying concentrations of trehalose determined 72 h after thawing. Cell viability was quantified using the MTS assay, and percentage cell viabilities were expressed against that of 10% DMSO. Data are presented as mean ± SD, n = 3, *p < 0.05, ***p < 0.001, and ****p < 0.0001. The cell viability of nonencapsulated ADSCs cryopreserved with 0.75 M trehalose (without hydrogels) was also determined in the same manner. (B) 3D confocal images of encapsulated ADSCs F-actin (cytoskeleton)-stained in green with the Phalloidin-iFluor 488 reagent. Z-stacked images were captured with CLSM using a Zeiss LSM 710 to analyze the change in the cell morphology and density in the entirety of the cell-laden hydrogels at referred time points. Cell adhesion to, and cell spread within, IPN hydrogels could be observed in all three dimensions (scale bar: 100 µm). (C) Quantification of intracellular human active caspase-3 expressed by encapsulated ADSCs after 48 h of culture with 10% DMSO or 0.75 M trehalose. A higher concentration (1800.87 vs 1250.43 pg/mL) of active caspase-3 could be detected when cryopreserved ADSCs were cultured with 10% DMSO compared to 0.75 M trehalose. Data are presented as mean ± SD and n = 3.
Supplier Page from Abcam for Human Active Caspase-3 Ser29 ELISA Kit